Articles From: Ultra Petroleum Announces Second Quarter And First Half 2014 Financial And Operating Results to Ultratech Announces Results of Annual Meeting of Stockholders


Ultra Petroleum Announces Second Quarter And First Half 2014 Financial And Operating Results Canada NewsWire HOUSTON , July 31, 2014 /CNW/ -- Ultra Petroleum Corp.
Sign-up for Ultra Petroleum Announces Second Quarter And First Half 2014 Financial And Operating Results investment picks
HOUSTON , Sept.
Sign-up for Ultra Petroleum Corp. Announces $700 Million Offering of Senior Notes investment picks
Ultra Petroleum Corp.
Sign-up for Ultra Petroleum Corp. Announces $700 Million Offering of Senior Notes investment picks
Ultra Petroleum Corp.
Sign-up for Ultra Petroleum Corp. Announces Pricing of $850 Million Senior Note Offering investment picks
HOUSTON , July 7, 2014 /PRNewswire/ -- Ultra Petroleum Corp .
Sign-up for Ultra Petroleum Corp. To Webcast Second Quarter 2014 Results investment picks
HOUSTON , July 31, 2014 /PRNewswire/ -- Ultra Petroleum Corp .
Sign-up for Ultra Petroleum Corp. To Webcast Second Quarter 2014 Results investment picks
NOVATO, Calif., July 14, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE) , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the closing of its public offering of 2,319,951 shares of common stock at a price to the public of $40.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 302,602 additional shares of common stock.
Sign-up for Ultragenyx Announces Closing of Public Offering of Common Stock and Exercise of Underwriters' Option to Purchase Additional Shares investment picks
NOVATO, Calif., July 1, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE) , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, announced the first patient screened and enrolled in the Phase 2 study of the human monoclonal anti-FGF23 antibody KRN23 (UX023) in pediatric patients with X-linked hypophosphatemia (XLH). XLH is an inherited metabolic bone disease characterized by short stature, skeletal deformities, bone pain, fractures, and muscle weakness.
Sign-up for Ultragenyx Announces Initiation of a Phase 2 Study of KRN23 for Pediatric X-Linked Hypophosphatemia in the US and EU investment picks
NOVATO, Calif., July 9, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE) , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the pricing of its underwritten public offering of 2,017,349 shares of its common stock at a price to the public of $40.00 per share, before underwriting discounts.
Sign-up for Ultragenyx Announces Pricing of Public Offering of Common Stock investment picks
NOVATO, Calif., July 7, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE) , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that it has commenced an underwritten public offering of 2,017,349 shares of its common stock.
Sign-up for Ultragenyx Announces Proposed Public Offering of Common Stock investment picks
NOVATO, Calif., June 24, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE) , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the presentation of results from a multiple-dose study, conducted by Kyowa Hakko Kirin Pharma, Inc. (KKP), of the investigational anti-FGF23 monoclonal antibody KRN23 (UX023) in adult patients with X-linked hypophosphatemia (XLH). XLH is an inherited metabolic bone disease characterized by short stature, skeletal deformities, bone pain, fractures, and muscle weakness.
Sign-up for Ultragenyx Announces Results From Phase 1/2 Study of KRN23 in X-linked Hypophosphatemia in Adults investment picks
NOVATO, Calif., July 23, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE) , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced it has appointed Sunil Agarwal, M.D. as its Chief Medical Officer and Senior Vice President, effective August 25, 2014.
Sign-up for Ultragenyx Appoints Sunil Agarwal, M.D. as Chief Medical Officer and Senior Vice President investment picks
NOVATO, Calif., Aug.
Sign-up for Ultragenyx Reports Second Quarter 2014 Financial Results and Corporate Update investment picks
Novato, CA, Aug.
Sign-up for Ultragenyx to Present at the Baird Health Care Conference investment picks
Novato, CA, June 18, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Emil D.
Sign-up for Ultragenyx to Present at the JMP Securities Healthcare Conference investment picks
Novato, CA, Sept.
Sign-up for Ultragenyx to Present at the Morgan Stanley Global Healthcare Conference investment picks
Novato, CA, Aug.
Sign-up for Ultragenyx to Present at Upcoming Investor Conferences investment picks
NEWARK, N.Y., July 31, 2014 (GLOBE NEWSWIRE) -- Ultralife Corporation (Nasdaq:ULBI) reported an operating loss from continuing operations of $1.3 million on revenue of $15.2 million for the quarter ended June 29, 2014.
Sign-up for Ultralife Corporation Reports Second Quarter Results investment picks
NEWARK, N.Y., July 16, 2014 (GLOBE NEWSWIRE) -- Ultralife Corporation (Nasdaq:ULBI) will report its second quarter results for the period ended June 29, 2014 before the market opens on Thursday, July 31, 2014.
Sign-up for Ultralife Corporation to Report Second Quarter Results on July 31, 2014 investment picks
2014/8/6
SAO PAULO , Aug.
Sign-up for Ultrapar announces its 2Q14 results investment picks
Subsidiaries of the Fund Close Acquisition of Shares from Founding Group NASSAU, Bahamas, Sept.
Sign-up for Ultrapetrol Announces Increase in Investment by Southern Cross investment picks
NASSAU, Bahamas, Aug.
Sign-up for Ultrapetrol Reports Financial Results for Second Quarter 2014 investment picks
Ultratech, Inc. (Nasdaq: UTEK) a leading supplier of lithography and laser-processing systems used to manufacture semiconductor devices and high-brightness LEDs (HB-LEDs), today announced that it will participate in the 6 th Annual CEO Investor Summit to be held Wednesday July 9, 2014 in San Francisco, California.
Sign-up for Ultratech Announces Participation in 6th Annual CEO Investor Summit 2014 investment picks
Ultratech, Inc. (Nasdaq: UTEK) a leading supplier of lithography, laser-processing and inspection systems used to manufacture semiconductor devices and high-brightness LEDs (HB-LEDs), today announced that it will present at the following conferences: To listen to the audio webcast of each presentation during or after the event, please visit http://ir.ultratech.com/ .
Sign-up for Ultratech Announces Participation in September Conferences investment picks
Ultratech, Inc. (Nasdaq: UTEK) a leading supplier of lithography, laser-processing and inspection systems used to manufacture semiconductor devices and high-brightness LEDs (HB-LEDs), today announced results from its annual meeting of stockholders held in Santa Clara, California.
Sign-up for Ultratech Announces Results of Annual Meeting of Stockholders investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Ultra Petroleum Announces Second Quarter And First Half 2014 Financial And Operating Results to Ultratech Announces Results of Annual Meeting of Stockholders
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices